China NMPA approves Sanofi & Regeneron’s Dupixent as an add-on maintenance treatment for adults with uncontrolled COPD: Paris Monday, September 30, 2024, 11:00 Hrs [IST] The Nat ...
3d
Dupixent approved in China as the first-ever biologic medicine for patients with COPDApproval follows EU approval of Dupixent for adults with ...
Terence Flynn, an analyst from Morgan Stanley, maintained the Buy rating on Regeneron (REGN – Research Report). The associated price ...
The CHMP recommended the label expansion of Dupixent in the European Union (EU) for eosinophilic esophagitis (EoE) in children down to 1 year of age. The recommendation is for children aged 1 to 11 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback